JP2023546293A5 - - Google Patents
Info
- Publication number
- JP2023546293A5 JP2023546293A5 JP2023548537A JP2023548537A JP2023546293A5 JP 2023546293 A5 JP2023546293 A5 JP 2023546293A5 JP 2023548537 A JP2023548537 A JP 2023548537A JP 2023548537 A JP2023548537 A JP 2023548537A JP 2023546293 A5 JP2023546293 A5 JP 2023546293A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063093255P | 2020-10-18 | 2020-10-18 | |
| US63/093,255 | 2020-10-18 | ||
| PCT/US2021/055311 WO2022082066A1 (en) | 2020-10-18 | 2021-10-15 | Anti-cspg4 binding agents, conjugates thereof and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023546293A JP2023546293A (ja) | 2023-11-01 |
| JP2023546293A5 true JP2023546293A5 (https=) | 2024-10-16 |
| JPWO2022082066A5 JPWO2022082066A5 (https=) | 2024-10-16 |
Family
ID=78709534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548537A Pending JP2023546293A (ja) | 2020-10-18 | 2021-10-15 | 抗ｃｓｐｇ４結合剤、そのコンジュゲートおよびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250213715A1 (https=) |
| EP (1) | EP4228704A1 (https=) |
| JP (1) | JP2023546293A (https=) |
| CN (1) | CN116782955A (https=) |
| CA (1) | CA3195865A1 (https=) |
| WO (1) | WO2022082066A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114836541B (zh) * | 2022-05-23 | 2026-02-17 | 中国药科大学 | 一种利用尿液微囊泡蛋白作为肾癌诊断标志物的应用 |
| CN120417935A (zh) * | 2022-10-25 | 2025-08-01 | 默沙东有限责任公司 | 依喜替康衍生的adc接头-载荷及其药物组合物和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004213053C1 (en) * | 2003-02-20 | 2009-07-16 | Seagen Inc. | Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| NZ565075A (en) * | 2005-06-20 | 2011-05-27 | Psma Dev Company Llc | PSMA antibody-drug conjugates |
| BR112014004168A2 (pt) * | 2011-08-23 | 2017-12-12 | Roche Glycart Ag | anticorpo biespecífico, composição farmacêutica, uso do anticorpo biespecífico, célula hospedeira procariótica ou eucariótica, método de produção de anticorpo e invenção |
| RU2014109038A (ru) * | 2011-08-23 | 2015-09-27 | Рош Гликарт Аг | Антитела к хондроитинсульфат протеогликану меланомы |
| WO2015012904A2 (en) * | 2012-12-13 | 2015-01-29 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
| RU2015140921A (ru) * | 2013-02-26 | 2017-04-03 | Роше Гликарт Аг | Антитела к mcsp |
-
2021
- 2021-10-15 JP JP2023548537A patent/JP2023546293A/ja active Pending
- 2021-10-15 WO PCT/US2021/055311 patent/WO2022082066A1/en not_active Ceased
- 2021-10-15 US US18/247,628 patent/US20250213715A1/en active Pending
- 2021-10-15 EP EP21811176.3A patent/EP4228704A1/en active Pending
- 2021-10-15 CN CN202180078901.0A patent/CN116782955A/zh active Pending
- 2021-10-15 CA CA3195865A patent/CA3195865A1/en active Pending